DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03306329 (ClinicalTrials.gov)	September 13, 2017	25/9/2017	DNS-7801 vs. Placebo in Parkinson's Disease	A Phase 2a, Double-Blind, Placebo-Controlled Two-Part Study To Investigate the Safety and Efficacy of Increasing Doses Of DNS-7801 In Parkinson's Disease (PD) Subjects With Motor Fluctuations	Parkinson's Disease	Drug: DNS-7801 (low-dose);Drug: DNS-7801 (high dose);Drug: Placebo	Dart NeuroScience, LLC	NULL	Terminated	30 Years	N/A	All	5	Phase 2	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT03306329
(ClinicalTrials.gov)

September 13, 2017

25/9/2017

DNS-7801 vs. Placebo in Parkinson's Disease

A Phase 2a, Double-Blind, Placebo-Controlled Two-Part Study To Investigate the Safety and Efficacy of Increasing Doses Of DNS-7801 In Parkinson's Disease (PD) Subjects With Motor Fluctuations

Parkinson's Disease

Drug: DNS-7801 (low-dose);Drug: DNS-7801 (high dose);Drug: Placebo

Dart NeuroScience, LLC

NULL

Terminated

30 Years

N/A

All

Phase 2

United States